| Literature DB >> 21283736 |
Agathe León1, César Cáceres, Emma Fernández, Paloma Chausa, Maite Martin, Carles Codina, Araceli Rousaud, Jordi Blanch, Josep Mallolas, Esteban Martinez, Jose L Blanco, Montserrat Laguno, Maria Larrousse, Ana Milinkovic, Laura Zamora, Neus Canal, Josep M Miró, Josep M Gatell, Enrique J Gómez, Felipe García.
Abstract
BACKGROUND: Antiretroviral therapy has changed the natural history of human immunodeficiency virus (HIV) infection in developed countries, where it has become a chronic disease. This clinical scenario requires a new approach to simplify follow-up appointments and facilitate access to healthcare professionals.Entities:
Mesh:
Year: 2011 PMID: 21283736 PMCID: PMC3024968 DOI: 10.1371/journal.pone.0014515
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Architecture of the Virtual Hospital.
The architecture of this web-based system has two parts. The first was the hospital infrastructure, where we added our server to the existing demilitarised zone (DMZ) of the hospital, which was protected by a firewall and integrated into the hospital's information system network. Health professionals accessed this server via the hospital's intranet. The second part was the home infrastructure, where the patient accessed the server via a basic broadband connection and, for security reasons, through a virtual private network (VPN).
Figure 2Electronic Health Record.
A. This figure shows the Virtual Consultation menu, where users select appointments conducted via standard care, videoconferencing, chat sessions or message exchanges. An electronic diary is also available so that at the end of the appointment, the patient and the professional could set a time for the next one. B. Here it shows an example of a teleconference appointment. Electronic Health Record contains demographic, epidemiological and clinical data (Hepatitis B or C coinfections; CD4 cell count and HIV-1 plasma viral load evolution; HAART-compliance and tolerance; comments of the infectious diseases physician) and is available to both professionals and patients during any of the sessions.
Figure 3Telepharmacy.
A. Telepharmacy allows the pharmacist to receive electronic prescriptions, to perform virtual consultations about compliance, adverse events or interactions, and to send the antiretroviral medication to the patient's home by courier. B. This figure shows how professionals track patient's HAART-history. C. In this section, the patients can also visualise the evolution of their own treatments on charts and consult basic information on the antiretroviral drugs available.
Baseline characteristics of the patients.
| CATEGORY | SUBCATEGORY | Cohort | Arm I | Arm II | P |
|
| 83 | 42 | 41 | ||
|
| 37 (34–43) | 37 (34–43) | 37 (34–43) | 0.9 | |
|
|
| 72 (87) | 36 (86) | 36 (88) | 0.56 |
|
| 11 (13) | 6 (14) | 5 (12) | ||
|
|
| 56 (68) | 25 (60) | 31 (76) | 0.36 |
|
| 20 (24) | 13 (31) | 7 (17) | ||
|
| 7 (8) | 4 (9) | 3 (7) | ||
|
|
| 66 (79) | 31 (74) | 35 (86) | 0.20 |
|
| 17 (21) | 11 (26) | 6 (14) | 0.20 | |
|
|
| 10 (12) | 5 (12) | 5 (12) | 0.97 |
|
| 41 (49) | 20 (48) | 21 (51) | 0.12 | |
|
| 32 (38) | 17 (40) | 15 (37) | 0.15 | |
|
|
| 6 (7) | 3 (7) | 3 (7) | 0.97 |
|
| 77 (93) | 39 (93) | 38 (93) | 0.12 | |
|
| 0 | 0 | 0 | 0.15 | |
|
| 10 (12) | 5 (12) | 5 (12) | 0.72 | |
|
| 9 (11) | 3 (7) | 6(15) | 0.17 | |
|
| 602 (471–726) | 585 (461–738) | 636 (511–718) | 0.66 | |
|
| 2.79 (0.14) | 2.79 (0.22) | 2.90 (0.20) | 0.40 | |
|
| 46 (55) | 24 (57) | 22 (54) | 0.52 |
P for comparison between arm I and II. *Median (IQR),
**(n, %),
***(n, % of patients on treatment),
****Mean (SE). HMS: Homosexual. HTS: Heterosexual. DU: Drug users.
Figure 4Patient availability.
91 patients were assessed for eligibility, but four were excluded due to a lack of broadband, while a further four declined to participate. Of the remaining 83 randomised patients, 42 were monitored during the first year through Virtual Hospital (Arm I) and 41 through standard care (Arm II). Patients switched their care arm in year two of the study. Over the two years of follow-up, seven patients (8%) discontinued the study: two were lost to follow-up (one left the country and one was whereabouts unknown), two left the Virtual Hospital because they disapproved of the system, two developed tumours (one non-Hodgkin lymphoma and one hepatocellular carcinoma), and one patient was killed in a traffic accident. Overall, 76 patients (92%) completed the study.
Technical evaluation by patients of the Virtual Hospital.
| CATEGORY | SUBCATEGORY | Patients |
|
| 76 | |
|
|
| 84 |
|
| 88 | |
|
| 78 | |
|
| 82 | |
|
| 65 | |
|
| 65 | |
|
| 85 | |
|
|
| 82 |
|
| 64 | |
|
| 67 | |
|
| 50 | |
|
| 85 | |
|
| 82 | |
|
|
| 80 |
|
| 17 | |
|
| 81 | |
|
|
| 83 |
|
| 15 | |
|
| 73 | |
|
| 5 | |
|
|
| 93 |
|
| 50 | |
|
|
| 81 |
|
|
| 84.6 |
|
|
| 69 |
|
| 90 | |
|
| 86 | |
|
| 74 | |
|
| 85 | |
|
| 68 | |
|
| 85 |
Questionnaire items were rated from 1 (most negative) to 5 (most positive).
*Proportion of patients who gave the two highest ratings (4 = “appropriate/agree”, or 5 = “Very appropriate/Totally agree”).
Study findings.
| CATEGORY | SUBCATEGORY | Cohort | Arm I | Arm II | P |
|
| 83 | 42 | 41 |
P for comparison between arm I and II.
*Mean (SE).
**(n, %). cART compliance: 93.4 means that patients took the 93.4% of the scheduled medication.
***(%). 4M: every 4 months. 6M: twice a year. 0: Never used. 1–4: Used from 1 to 4 times a year. 1–2: Used from 1 to 2 times a year.